Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Arch Otolaryngol Head Neck Surg ; 127(8): 970-4, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11493208

ABSTRACT

OBJECTIVE: To evaluate the feasibility and predictive ability of the sentinel node localization technique for patients with squamous cell carcinoma of the oral cavity or oropharynx and clinically negative necks. DESIGN: Prospective, efficacy study comparing the histopathologic status of the sentinel node with that of the remaining neck dissection specimen. SETTING: Tertiary referral center. PATIENTS: Patients with T1 or T2 disease and clinically negative necks were eligible for the study. Nine previously untreated patients with oral cavity or oropharyngeal squamous cell carcinoma were enrolled in the study. INTERVENTIONS: Unfiltered technetium Tc 99m sulfur colloid injections of the primary tumor and lymphoscintigraphy were performed on the day before surgery. Intraoperatively, the sentinel node(s) was localized with a gamma probe and removed after tumor resection and before neck dissection. MAIN OUTCOME MEASURES: The primary outcome was the negative predictive value of the histopathologic status of the sentinel node for predicting cervical metastases. RESULTS: Sentinel nodes were identified in 9 previously untreated patients. In 5 patients, there were no positive nodes. In 4 patients, the sentinel nodes were the only histopathologically positive nodes. In previously untreated patients, the sentinel node technique had a negative predictive value of 100% for cervical metastasis. CONCLUSIONS: Our preliminary investigation shows that sentinel node localization is technically feasible in head and neck surgery and is predictive of cervical metastasis. The sentinel node technique has the potential to decrease the number of neck dissections performed in clinically negative necks, thus reducing the associated morbidity for patients in this group.


Subject(s)
Carcinoma, Squamous Cell/secondary , Lymph Nodes/diagnostic imaging , Mouth Neoplasms/pathology , Oropharyngeal Neoplasms/pathology , Sentinel Lymph Node Biopsy , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/surgery , Feasibility Studies , Female , Humans , Lymph Node Excision , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Middle Aged , Mouth Neoplasms/surgery , Neck , Oropharyngeal Neoplasms/surgery , Predictive Value of Tests , Prospective Studies , Radionuclide Imaging , Radiopharmaceuticals , Technetium Tc 99m Sulfur Colloid
2.
Int J Radiat Oncol Biol Phys ; 50(3): 695-704, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11395238

ABSTRACT

PURPOSE: To assess long-term xerostomia in patients receiving parotid-sparing radiation therapy (RT) for head-and-neck cancer, and to find the patient and therapy-related factors that affect its severity. PATIENTS AND METHODS: From March 1994 through January 2000, 84 patients received comprehensive bilateral neck RT using conformal and multisegmental intensity-modulated RT (IMRT) aiming to spare the major salivary glands. Before RT and periodically through 2 years after the completion of RT, salivary flow rates from each of the major salivary glands were selectively measured. At the same time intervals, each patient completed an 8-item self-reported xerostomia-specific questionnaire (XQ). To gain a relative measure of the effect of RT on the minor salivary glands, whose output could not be measured, the surfaces of the oral cavity (extending to include the surface of the base of tongue) were outlined in the planning CT scans. The mean doses to the new organ ("oral cavity") were recorded. Forty-eight patients receiving unilateral neck RT were similarly studied and served as a benchmark for comparison. Factors predicting the XQ scores were analyzed using a random-effects model. RESULTS: The XQ was found to be reliable and valid in measuring patient-reported xerostomia. The spared salivary glands which had received moderate doses in the bilateral RT group recovered to their baseline salivary flow rates during the second year after RT, and the spared glands in the unilateral RT group, which had received very low doses, demonstrated increased salivary production beyond their pre-RT levels. The increase in the salivary flow rates during the second year after RT paralleled an improvement in xerostomia in both patient groups. The improvement in xerostomia was faster in the unilateral compared with the bilateral RT group, but the difference narrowed at 2 years. The major salivary gland flow rates had only a weak correlation with the xerostomia scores. Factors found to be independently associated with the xerostomia scores were the pre-RT baseline scores, the time since RT, and the mean doses to the major salivary glands (notably to the submandibular glands) and to the oral cavity. CONCLUSION: An improvement over time in xerostomia, occurring in tandem with rising salivary production from the spared major salivary glands, suggests a long-term clinical benefit from their sparing. The oral cavity mean dose, representing RT effect on the minor salivary glands, was found to be a significant, independent predictor of xerostomia. Thus, in addition to the major salivary glands, sparing the uninvolved oral cavity should be considered as a planning objective to further reduce xerostomia.


Subject(s)
Head and Neck Neoplasms/radiotherapy , Parotid Gland/radiation effects , Radiation Protection , Xerostomia/etiology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Parotid Gland/metabolism , Radiotherapy, Conformal/adverse effects , Risk Factors , Salivation/radiation effects , Submandibular Gland/metabolism , Submandibular Gland/radiation effects
3.
Int J Radiat Oncol Biol Phys ; 50(2): 377-85, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11380224

ABSTRACT

PURPOSE: To review the outcome of head-and-neck cancer patients re-irradiated using conformal radiation. PATIENTS AND METHODS: From 1983 to 1999, 60 patients with recurrent or new primary head-and-neck cancer received re-irradiation at the University of Michigan. Twenty patients were excluded due to the planned cumulative radiation dose being less than 100 Gy (18) and absence of prior radiation details (2), leaving 40 patients. Thirty-five patients were re-irradiated for unresectable disease, while 4 patients received adjuvant re-irradiation for high-risk disease. Thirty-eight patients had recurrences from previously treated cancer (19 regional, 14 local, 5 regional and local), and 2 patients had new primary tumors. The median time from the first course of radiation to re-irradiation was 21 months. Thirty-one patients (78%) were re-irradiated with curative intent, whereas 9 were treated with palliative intent. Re-irradiation was delivered using conformal techniques in the majority of patients and with concurrent chemotherapy in 14 patients. The median re-irradiation dose was 60 Gy. The median cumulative dose received was 121 Gy. Five patients (13%) did not complete their prescribed course of re-irradiation. RESULTS: The median survival following completion of re-irradiation was 12.5 months. The 1- and 2-year actuarial survival rates were 51.1% and 32.6%, respectively. On multivariate analysis, palliative intent of treatment, tumor bulk, and tumor site other than nasopharynx or larynx were associated with worse survival. The patients treated for unresectable disease did no worse than those treated adjuvantly. The median times to relapse-free survival, local-regional recurrence (LRR)-free survival, and ultimate LRR-free survival (allowing for surgical salvage) were 3.9 months, 7.8 months, and 8.7 months, respectively. Seven patients (18%) are presently alive with no evidence of disease, with a median follow-up of 49.9 months (range 3.3-78.9). Severe radiation-induced complications were seen in 7 patients (18%). Two other patients developed orocutaneous fistulas in the presence of tumor recurrence. Moderate fibrosis and trismus were common. CONCLUSION: Despite the use of conformal techniques, the prognosis of patients treated with re-irradiation is poor, and complications are not infrequent. A subset of patients is salvageable, and high-dose re-irradiation should be considered in selected patients.


Subject(s)
Head and Neck Neoplasms/radiotherapy , Neoplasm Recurrence, Local/radiotherapy , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carboplatin/administration & dosage , Cisplatin/administration & dosage , Combined Modality Therapy , Disease-Free Survival , Female , Head and Neck Neoplasms/drug therapy , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Radiotherapy, Conformal/adverse effects , Retrospective Studies , Survival Rate , Treatment Outcome
4.
J Clin Oncol ; 19(3): 792-9, 2001 Feb 01.
Article in English | MEDLINE | ID: mdl-11157033

ABSTRACT

PURPOSE: To examine the feasibility and dose-limiting toxicity (DLT) of once-weekly gemcitabine at doses predicted in preclinical studies to produce radiosensitization, concurrent with a standard course of radiation for locally advanced head and neck cancer. Tumor incorporation of gemcitabine triphosphate (dFdCTP) was measured to assess whether adequate concentrations were achieved at each dose level. PATIENTS AND METHODS: Twenty-nine patients with unresectable head and neck cancer received a course of radiation (70 Gy over 7 weeks, 5 days weekly) concurrent with weekly infusions of low-dose gemcitabine. Tumor biopsies were performed after the first gemcitabine infusion (before radiation started), and the intracellular concentrations of dFdCTP were measured. RESULTS: Severe acute and late mucosal and pharyngeal-related DLT required de-escalation of gemcitabine dose in successive patient cohorts receiving dose levels of 300 mg/m(2)/wk, 150 mg/m(2)/wk, and 50 mg/m(2)/wk. No DLT was observed at 10 mg/m(2)/wk. The rate of endoscopy- and biopsy-assessed complete tumor response was 66% to 87% in the various cohorts. Tumor dFdCTP levels were similar in patients receiving 50 to 300 mg/m(2) (on average, 1.55 pmol/mg, SD 1.15) but were barely or not detectable at 10 mg/m(2). CONCLUSION: A high rate of acute and late mucosa-related DLT and a high rate of complete tumor response were observed in this regimen at the dose levels of 50 to 300 mg/m(2), which also resulted in similar, subcytotoxic intracellular dFdCTP concentrations. These results demonstrate significant tumor and normal tissue radiosensitization by low-dose gemcitabine. Different regimens of combined radiation and gemcitabine should be evaluated, based on newer preclinical data promising an improved therapeutic ratio.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Deoxycytidine/adverse effects , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Radiation-Sensitizing Agents/adverse effects , Adult , Aged , Aged, 80 and over , Antimetabolites, Antineoplastic/pharmacokinetics , Antimetabolites, Antineoplastic/therapeutic use , Biopsy , Combined Modality Therapy , Cytosine Nucleotides/metabolism , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacokinetics , Deoxycytidine/therapeutic use , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Radiation-Sensitizing Agents/pharmacokinetics , Radiation-Sensitizing Agents/therapeutic use , Radiotherapy/adverse effects , Gemcitabine
5.
Laryngoscope ; 110(12): 2074-80, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11129024

ABSTRACT

OBJECTIVES/HYPOTHESIS: We designed two sequential trials of induction chemotherapy followed by definitive radiation in patients with potentially resectable head and neck cancer to determine whether organ preservation is feasible without apparent compromise of survival Study Design Both trials were Phase II studies. METHODS: Two clinical trials were conducted sequentially at the University of Michigan. Fifty-two patients enrolled in the first study and were treated with a planned three cycles of carboplatin and 5-fluorouracil. Patients who achieved at least 50% reduction in the size of the primary tumor received definitive radiation therapy, to a dose of 6600 to 7380 cGy. Patients with minimal response or progression had immediate salvage surgery. Thirty-seven patients enrolled in the second trial, in which the chemotherapy consisted of carboplatin, 5-fluororuracil, and leukovorin. Responders were treated with accelerated radiation therapy, to a total dose of 7120 cGy delivered in 41 fractions over 5.5 weeks. RESULTS: Toxicity and response were similar in both trials; therefore, the results are reported first separately and then combined for all 89 patients. Tumor sites included: oropharynx, 55 patients; hypopharynx, 34 patients. Eighty-three percent of patients tolerated all three cycles of chemotherapy and toxicity was mild. Response to chemotherapy was: 48% complete response at the primary tumor site, and 34% partial response at the primary tumor site. Initial organ preservation at individual tumor sites was: oropharynx, 58%; hypopharynx, 59%. Median survival was 28 months, and survival at 3 and 5 years was 40% and 24%, respectively. CONCLUSIONS: These two regimens were well tolerated, and survival did not appear to be compromised by organ preservation treatment compared with historical controls. This approach warrants further investigation, particularly in those patients for whom surgery could be functionally debilitating.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Hypopharyngeal Neoplasms/drug therapy , Oropharyngeal Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Carboplatin/therapeutic use , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/surgery , Chemotherapy, Adjuvant , Disease-Free Survival , Female , Fluorouracil/therapeutic use , Humans , Hypopharyngeal Neoplasms/mortality , Hypopharyngeal Neoplasms/radiotherapy , Hypopharyngeal Neoplasms/surgery , Leucovorin/therapeutic use , Male , Middle Aged , Oropharyngeal Neoplasms/mortality , Oropharyngeal Neoplasms/radiotherapy , Oropharyngeal Neoplasms/surgery , Radiotherapy Dosage , Survival Analysis
6.
J Voice ; 14(3): 378-86, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11021505

ABSTRACT

Unilateral vocal fold paralysis is a common clinical problem which frequently causes severe dysphonia. Various treatment options exist for this condition, with the type I thyroplasty being one of the more commonly performed surgical procedures for vocal rehabilitation. The Voice-Related Quality of Life (V-RQOL) Measure is a validated outcomes instrument for voice disorders. This study measured the V-RQOL of patients with unilateral vocal fold paralysis who had undergone a type I thyroplasty and compared these scores to those of patients with untreated and uncompensated unilateral vocal fold paralysis and to normals. Treated patients had significantly higher domain and overall V-RQOL scores than untreated patients, but also scored lower than normals. These differences were true across gender and age. Patients who were more distant from surgery had lower V-RQOL scores than those who had more recently been treated. It is concluded that type I thyroplasty leads to a significantly higher V-RQOL for patients with unilateral vocal fold paralysis. This study also demonstrates further the utility of patient-oriented measures of treatment outcome.


Subject(s)
Quality of Life , Thyroid Gland/surgery , Vocal Cord Paralysis/surgery , Voice Disorders/diagnosis , Female , Humans , Male , Middle Aged , Postoperative Period , Severity of Illness Index , Surveys and Questionnaires
7.
J Digit Imaging ; 13(2 Suppl 1): 93-6, 2000 May.
Article in English | MEDLINE | ID: mdl-10847372

ABSTRACT

This presentation describes our experiences using a web-based viewing software and a browser to view our picture archiving and communication system (PACS) images at a remote site with cable modem-internet communications. Our testing shows that using a cable modem to access our radiology webserver produces acceptable transmission speeds to remote sites. The average time-to-display (TTD) for 16 computed tomography (CT) images on the web-based intranet system in our hospital was 7 to 8 seconds. Using a cable modem and comparable equipment at a remote site, the average TTD is 16 seconds over the internet. The TTD does not significantly change during various hours of the day. Security for our hospital-based PACS is provided by a firewall. Access through the firewall is accomplished using virtual private network (VPN) software, a secure ID, and encryption. We have found that this is a viable method for after-hours subspecialty radiology consultation.


Subject(s)
Internet/instrumentation , Modems , Radiology Information Systems/instrumentation , Tomography, X-Ray Computed/instrumentation , Academic Medical Centers , Computer Security , Computer Systems , Hospital Information Systems , Humans , Ohio , Software Design , Teleradiology/instrumentation
8.
Laryngoscope ; 110(4): 620-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10764008

ABSTRACT

OBJECTIVE: To assess quality of life (QOL) in patients with head and neck cancer who underwent neck dissection and to compare QOL scores for patients in whom the spinal accessory nerve (CN XI) was resected or preserved. SETTING AND DESIGN AND OUTCOMES MEASURES: Three hundred ninety-seven patients who had undergone treatment for head and neck cancer completed the University of Michigan Head and Neck Quality of Life (HNQOL) instrument, the Medical Outcomes Study SF-12 General Health Survey, and questions on "pain despite pain medications" and headaches. RESULTS: Of the 397 patients, 222 had no neck dissection, 46 had neck dissections resecting CN XI, and 129 had dissection sparing CN XI. Of the latter group, 68 patients had dissections sparing level V and 61 dissections included level V. Age, sex, primary site distribution, and T stage were not different between the groups. Patients who had neck dissections sparing CN XI had better scores on the HNQOL pain domain (P = .002), had less shoulder or neck pain (P = .003), and took pain medications less frequently (P = .0004) compared with patients who had neck dissections sacrificing CN XI. When CN XI was preserved, patients who had no level V dissection had better pain domain scores (P = .03) and eating domain scores (P = .007) on the HNQOL, had less shoulder or neck pain (P = .006), and had less physical problems (P = .03) than patients who had level V dissected. On multivariate analysis, pain-related QOL scores after neck dissection were significantly better (P < .01) if patients had dissections with preservation of CN XI and if level V was not dissected. CONCLUSION: Neck dissections sparing CN XI are associated with better pain scores on the HNQOL, less shoulder and neck pain, and less need for medications. When CN XI is spared, not dissecting level V of the neck is associated with better HNQOL pain scores, less shoulder or neck pain, and fewer physical problems.


Subject(s)
Accessory Nerve/surgery , Neck Dissection , Otorhinolaryngologic Neoplasms/surgery , Pain Measurement , Pain, Postoperative/etiology , Quality of Life , Adult , Aged , Female , Humans , Male , Middle Aged , Neck Pain/etiology , Neoplasm Staging , Otorhinolaryngologic Neoplasms/pathology , Otorhinolaryngologic Neoplasms/radiotherapy , Radiotherapy, Adjuvant , Shoulder Pain/etiology , Sickness Impact Profile
9.
Otolaryngol Clin North Am ; 33(2): 441-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10736417

ABSTRACT

Allergic fungal rhinosinusitis (AFRS) has a worldwide distribution. This survey of 20 otolaryngologic practices throughout the United States confirmed a variation in the frequency of AFRS relative to endoscopic sinus procedures performed for all other diagnoses. The highest incidence occurred in Memphis, Tennessee at 23%, with three other southern practices reporting a frequency of at least 10%. In the northern locations the frequency ranged from 0 to 4%. No correlation with mould counts was demonstrated, possibly because of incomplete mould data relative to most of the surgical locations.


Subject(s)
Mycoses , Rhinitis, Allergic, Perennial/epidemiology , Sinusitis/epidemiology , Humans , Rhinitis, Allergic, Perennial/complications , Rhinitis, Allergic, Perennial/microbiology , Sinusitis/complications , Sinusitis/microbiology , United States/epidemiology
10.
Hematol Oncol Clin North Am ; 13(4): 849-65, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10494518

ABSTRACT

Patient-oriented QOL evaluation has become a useful adjunct to the more traditional measures used to assess the effectiveness of new therapies. In the future, it will be especially important to assess QOL outcomes of newer multimodality therapies and of conventional therapies in head and neck oncology, particularly those that are expensive or labor-intensive. Promising areas for QOL research include assessments of therapies for which survival rates are similar, but patient-oriented QOL outcomes or cost may differ greatly, such as treatment of oropharyngeal cancer or early glottic cancer, organ preservation strategies, and free flap reconstruction of surgical defects. Finally, valid QOL information will help oncologists understand their patients' physical and emotional impairments better and therefore better assess, treat, and rehabilitate patients with head and neck cancer.


Subject(s)
Head and Neck Neoplasms , Quality of Life , Adaptation, Psychological , Deglutition , Eating , Head and Neck Neoplasms/physiopathology , Head and Neck Neoplasms/psychology , Humans , Pain Management , Speech , Treatment Outcome
11.
Otolaryngol Head Neck Surg ; 120(6): 852-9, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10352439

ABSTRACT

A multidimensional Head and Neck Quality of Life (HNQOL) instrument and a general health status measure were administered to 397 patients with head and neck cancer. Scores for the 4 domains of the HNQOL (communication, eating, pain, and emotional well-being) were calculated. Patient demographics, comorbidities, clinical characteristics, treatment data, disability status, and a global "overall bother" score were assessed. When compared with the US population aged 55 to 64 years, the group had significantly worse scores in the 8 health domains of the SF-36. Patients' overall bother scores from the head and neck cancer treatment correlated best with the HNQOL emotion domain (r = 0.71) and the HNQOL pain domain (r = 0.63), and least with the patients' perception of their response to treatment (r = 0.39). Pain, eating, emotion, physical component summary score, age, and an interaction term between eating and emotion were significant predictors for overall bother. Of the 217 patients who were working before the diagnosis of cancer, 74 (34. 1%) reported that they had become disabled. Patients who had more than 1 type of treatment were 5.9 times more likely to report themselves as disabled (odds ratio [OR] = 5.94, P < 0.01), even after adjusting for age, emotion score, and physical component summary score, which were other factors that predicted disability.


Subject(s)
Head and Neck Neoplasms , Health Status Indicators , Quality of Life , Comorbidity , Cross-Sectional Studies , Head and Neck Neoplasms/epidemiology , Head and Neck Neoplasms/pathology , Humans , Neoplasm Staging
12.
J Digit Imaging ; 12(2 Suppl 1): 112-5, 1999 May.
Article in English | MEDLINE | ID: mdl-10342184

ABSTRACT

Now that picture archiving and communications systems (PACS) has matured, our challenge is to make the images available to the referring physician and, in a teaching institution, to make these images available for conferences and rounding. One solution is the distribution of the images using web-based technology. We investigated a web-based add-on to our PACS to determine the characteristics of the personal computer that will make this technology useful and affordable. We found that images can be viewed easily through a web-based system. We found that the optimal system to view these images at a reasonable speed and a reasonable cost is on with a medium-range processor (200 to 300 MHz) and a large amount of inexpensive RAM, at least 64 Mb.


Subject(s)
Diagnostic Imaging , Internet , Microcomputers , Radiology Information Systems , Costs and Cost Analysis , Data Display , Humans , Image Processing, Computer-Assisted , Microcomputers/classification , Microcomputers/economics , Radiology Information Systems/economics , Radiology Information Systems/instrumentation , Radiology Information Systems/organization & administration , Software , Time Factors
13.
J Digit Imaging ; 12(2 Suppl 1): 116-8, 1999 May.
Article in English | MEDLINE | ID: mdl-10342185

ABSTRACT

Now that picture archiving and communications systems (PACS) has matured, our challenge is to make the images available to the referring physician and, in a teaching institution, to make these images available for conferences and rounding. One solution is the distribution of the images using web-based technology. We investigated a web-based add-on to our PACS to determine the characteristics of the personal computer that will make this technology useful and affordable. We found that images can be viewed easily through a web-based system. We found that the optimal system to view these images at a reasonable speed and a reasonable cost is on with a medium-range processor (200 to 300 MHz) and a large amount of inexpensive RAM, at least 64 Mb.


Subject(s)
Diagnostic Imaging , Image Processing, Computer-Assisted , Internet , Radiology Information Systems , Data Display , Humans , Microcomputers , Radiology Information Systems/economics , Radiology Information Systems/organization & administration , Software , Telephone , Time Factors
14.
Acta Otorhinolaryngol Belg ; 53(3): 271-5, 1999.
Article in English | MEDLINE | ID: mdl-10635407

ABSTRACT

PURPOSE: To develop techniques which facilitate sparing of the major salivary glands while adequately treating the targets in patients requiring comprehensive bilateral neck irradiation (RT). PATIENTS AND METHODS: Conformal and static, multisegmental intensity modulated (IMRT) techniques have been developed. The salivary flow rates before and periodically after RT have been measured selectively from each major salivary gland and the residual flows correlated with glands' dose volume histograms. Subjective xerostomia questionnaires have been developed and validated. The pattern of local-regional recurrences has been examined using CT scans at the time of recurrence, transferring the recurrence volumes to the planning CT scans and regenerating the dose distributions at the recurrence sites. RESULTS: Target coverage and dose homogeneity in IMRT treatment plans were found to be significantly better than standard RT plans. Significant parotid gland sparing was achieved. The relationships among dose, irradiated volume and saliva flow rates from the parotid glands were characterized by dose and volume thresholds. A mean dose of 26 Gy was found to be the threshold for stimulated saliva. Subjective xerostomia was significantly reduced in patients irradiated with parotid sparing techniques, compared to patients with similar tumors treated with standard RT. The large majority of recurrences occurred inside high-risk targets. CONCLUSIONS: Tangible gains in salivary gland sparing and target coverage are being achieved and an improvement in some measures of quality of life is suggested by our findings. A mean parotid gland dose of < or = 26 Gy should be a planning objective if significant parotid function preservation is desired. The pattern of recurrence suggests that careful escalation of the dose to targets judged to be at highest risk may improve tumor control.


Subject(s)
Head and Neck Neoplasms/radiotherapy , Parotid Gland/metabolism , Quality of Life , Radiotherapy, Conformal , Dose-Response Relationship, Radiation , Head and Neck Neoplasms/psychology , Humans , Neoplasm Recurrence, Local , Parotid Gland/radiation effects , Radiotherapy Dosage , Saliva/metabolism , Xerostomia/prevention & control
15.
Arch Otolaryngol Head Neck Surg ; 124(9): 964-71, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9738804

ABSTRACT

OBJECTIVE: To assess long-term quality of life in surviving patients with advanced laryngeal cancer. DESIGN: A follow-up long-term quality-of-life survey of patients randomized to the Veterans Affairs Laryngeal Cancer Study No. 268 on induction chemotherapy and radiation (CT + RT) vs surgery and RT. SETTING AND PATIENTS: Forty-six (71%) of the 65 surviving patients with prior stage III or IV laryngeal cancer who could be contacted completed the survey: 25 from the surgery and RT group and 21 from the CT + RT group. Baseline demographic and clinical characteristics among survey respondents were similar, except that those in the CT + RT group were significantly older (mean, 61.2 years) than those in the surgery and RT group (mean, 55.7 years; P<.05). INTERVENTIONS AND MAIN OUTCOME MEASURES: Patients completed the University of Michigan Head and Neck Quality of Life (HNQOL) instrument, the Medical Outcomes Studies Short-Form 36 (SF-36) general health survey, the Beck Depression Inventory as well as smoking and alcohol consumption surveys. RESULTS: Patients randomized to the CT + RT group had significantly better (P<.05) quality-of-life scores on the SF-36 mental health domain (76.0) than the surgery and RT group (63.0), and also had better HNQOL pain scores (81.3 vs 64.3). Compared with patients who underwent laryngectomy, patients with intact larynges (CT + RT with larynx) had significantly less bodily pain (88.5 vs 56.5), better scores on the SF-36 mental health (79.8 vs 64.7), and better HNQOL emotion (89.7 vs 79.4) scores. More patients in the surgery and RT group (28%) were depressed than in the CT + RT group (15%). CONCLUSION: Better quality-of-life scores in the CT + RT groups appear to be related to more freedom from pain, better emotional well-being, and lower levels of depression than to preservation of speech function.


Subject(s)
Laryngeal Neoplasms/rehabilitation , Quality of Life , Alcohol Drinking/epidemiology , Attitude to Health , Combined Modality Therapy , Depression/epidemiology , Female , Health Status , Humans , Laryngeal Neoplasms/psychology , Laryngeal Neoplasms/therapy , Laryngectomy , Male , Middle Aged , Smoking/epidemiology , Speech, Alaryngeal , Time Factors , United States/epidemiology , Veterans
16.
Laryngoscope ; 108(1 Pt 1): 115-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9432079

ABSTRACT

A 36-year-old renal transplant recipient taking cyclosporin A presented with bilateral nasal polypoid lesions involving the nasal septum and lateral nasal walls. Pathologic findings from surgical excision demonstrated inverted papilloma (IP) with focal atypia and mild dysplasia. DNA extracted from the tissue was tested with the polymerase chain reaction (PCR) using human papillomavirus (HPV) E6 and L1 consensus primers. This revealed amplification of the expected size fragment consistent with the presence of HPV DNA. Hybridization of PCR products with HPV type-specific oligonucleotide probes revealed a strong signal with only HPV 6. This result was confirmed by PCR amplification with HPV 6 type-specific primers. RNA extracted from the tissue was subjected to reverse transcription PCR (RT-PCR) with a primer pair specific for viral E6/E7 transcripts. The HPV early proteins, E6 and E7, are the transforming proteins implicated as critical for tumorigenesis. RT-PCR experiments generated products representing the E1/E4 spliced transcript originating from the E6/E6 promoter and a smaller unclassified fragment. These results provide evidence for HPV 6 E6/E7 expression in IP, lending credence to the concept that HPV may play a role in the origin of this neoplasm. Histologically normal nasal tissue from the same patient contained HPV DNA and similar transcripts to those described in the IP specimen.


Subject(s)
Kidney Transplantation , Nose Neoplasms/virology , Papilloma, Inverted/virology , Papillomaviridae/isolation & purification , Postoperative Complications , Adult , Blotting, Southern , DNA Primers , DNA, Viral/isolation & purification , Female , Humans , Immunocompromised Host , Kidney Transplantation/immunology , Neoplasm Recurrence, Local , Nose Neoplasms/pathology , Papilloma, Inverted/classification , Papillomaviridae/classification , Polymerase Chain Reaction/methods
17.
Otolaryngol Head Neck Surg ; 117(4): 372-9, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9339799

ABSTRACT

In an attempt to establish a standardized rating system for CT of the paranasal sinuses, the Committee on Rhinology and Paranasal Sinus Disease of the American Academy of Otolaryngology-Head and Neck Surgery instituted a protocol for the review of sinus CT scans at six international sites. Fifty identical scans were rated by four otolaryngologists at each site according to five established sinus CT staging systems. Twenty of 24 reviewers repeated the rating session at least 1 week later to determine intrarater variability. The number of CT scans that could not be classified by a particular rating system ranged from 1.3% to 5.5%. The range of intrarater agreement (kappa = 0.39 to 0.74) exceeded that of interrater agreement (kappa = 0.18 to 0.49). A skewed distribution of CT scans resulted in a system with high rater agreement but poor ability to differentiate among disease states. The use of a numeric rating system to assign a score to each scan produced a comprehensive and disease-sensitive system, but one with low rater agreement. A precise definition of mucosal thickening in terms of millimeters appeared to enhance the raters' ability to assign stage and improve a system's comprehensiveness and reproducibility. On the basis of these findings, recommendations are made for the use of CT rating systems to study clinical outcomes in patients with chronic sinusitis.


Subject(s)
Paranasal Sinus Diseases/diagnostic imaging , Tomography, X-Ray Computed , Humans , Observer Variation , Paranasal Sinuses/diagnostic imaging , Reproducibility of Results , Statistics as Topic
18.
Arch Otolaryngol Head Neck Surg ; 123(10): 1081-7, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9339985

ABSTRACT

OBJECTIVES: To assess whether continuous facial nerve monitoring during parotidectomy is associated with a lower incidence of facial nerve paresis or paralysis compared with parotidectomy without monitoring and to assess the cost of such monitoring. DESIGN: A retrospective analysis of outcomes for patients who underwent parotidectomy with or without continuous facial nerve monitoring. SETTING: University medical center. PATIENTS: Fifty-six patients undergoing parotidectomy in whom continuous electromyographic monitoring was used and 61 patients in whom it was not used. MAIN OUTCOME MEASURES: (1) The incidence of early and persistent facial nerve paresis or paralysis and (2) the cost associated with facial nerve monitoring. RESULTS: Early, unintentional facial weakness was significantly lower in the group monitored by electromyograpy (43.6%) than in the unmonitored group (62.3%) (P=.04). In the subgroup of patients without comorbid conditions or surgeries, early weakness in the monitored group (33.3%) remained statistically lower than the rate of early weakness in the unmonitored group (57.5%) (P=.03). There was no statistical difference in the final facial nerve function or incidence of permanent nerve injury between the groups or subgroups. After multivariate analysis, nonmonitored status (odds ratio [OR], 3.22), advancing age (OR, 1.47 per 10 years), and longer operative times (OR, 1.3 per hour) were the only significant independent predictive variables significantly associated with early postoperative facial weakness. The incremental cost of facial nerve monitoring was $379. CONCLUSIONS: The results suggest that continuous electromyographic monitoring of facial muscle during primary parotidectomy reduces the incidence of short-term postoperative facial paresis. Advantages and disadvantages of this technique need to be considered together with the additional costs in deciding whether routine use of continuous monitoring is a useful, cost-effective adjunct to parotid surgery.


Subject(s)
Electromyography , Facial Nerve/physiopathology , Facial Paralysis/prevention & control , Parotid Diseases/surgery , Parotid Gland/surgery , Postoperative Complications/prevention & control , Cost-Benefit Analysis , Electromyography/economics , Facial Paralysis/etiology , Facial Paralysis/physiopathology , Female , Humans , Incidence , Male , Middle Aged , Monitoring, Intraoperative/economics , Postoperative Complications/etiology , Postoperative Complications/physiopathology , Retrospective Studies
19.
Arch Otolaryngol Head Neck Surg ; 123(10): 1125-32, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9339991

ABSTRACT

BACKGROUND: The disfigurement and dysfunction associated with head and neck cancer affect emotional well-being and some of the most basic functions of life. Most cancer-specific quality-of-life assessments give a single composite score for head and neck cancer-related quality of life. OBJECTIVE: To develop and evaluate an improved multidimensional instrument to assess head and neck cancer-related functional status and well-being. METHODS: The item selection process included literature review, interviews with health care workers, and patient surveys. A survey with 37 disease-specific questions and the SF-12 survey were administered to 253 patients in 3 large medical centers. Factor analysis was performed to identify disease-specific domains. Domain scores were calculated as the standardized score of the component items. These domains were assessed for construct validity based on clinical hypotheses and test-retest reliability. RESULTS: Four relevant domains were identified: Eating (6 items), Communication (4 items), Pain (4 items), and Emotion (6 items). Each had an internal consistency (Cronbach alpha value) of greater than 0.80. Construct validity was demonstrated by moderate correlations with the SF-12 Physical and Mental component scores (r=0.43-0.60). Test-retest reliability for each domain demonstrated strong reliability between the 2 time points. Correlations were strong for each individual question, ranging from 0.53 to 0.93. Construct validity testing demonstrated that the direction of differences for each domain were as hypothesized. CONCLUSION: The Head and Neck Quality of Life questionnaire is a promising multidimensional tool with which to assess head and neck cancer-specific quality of life.


Subject(s)
Head and Neck Neoplasms/complications , Head and Neck Neoplasms/psychology , Quality of Life , Surveys and Questionnaires , Factor Analysis, Statistical , Humans , Pain/etiology , Predictive Value of Tests , Reproducibility of Results , Stress, Psychological/etiology
20.
Int J Radiat Oncol Biol Phys ; 36(2): 469-80, 1996 Sep 01.
Article in English | MEDLINE | ID: mdl-8892473

ABSTRACT

PURPOSE: To minimize xerostomia in patients receiving bilateral head and neck irradiation (RT) by using conformal RT planning to spare a significant volume of one parotid gland from radiation. METHODS AND MATERIALS: The study involved 15 patients with head and neck tumors in whom bilateral neck radiation was indicated. The major salivary glands and the targets (tumor, surgical bed, metastases to lymph nodes, and the locations of lymph nodes at risk for metastases) were outlined on axial computed tomography images. Beam's-eye view (BEV) displays were used to construct conformal beams that delivered the prescribed doses to the targets while sparing from direct radiation most of one parotid gland. The gland that was planned to be spared resided in the neck side that was judged in each patient to be at a lesser risk of metastatic disease. Major salivary gland flow rates and the responses to a subjective xerostomia questionnaire were assessed before, during, and after radiation. RESULTS: Radiation planning for patients with central oropharyngeal tumors required the generation of multiple axial nonopposed beams. The resulting isodoses encompassed the targets, including the retropharyngeal nodes and the jugular nodes up to the base of skull bilaterally, while limiting the dose to the oral cavity, spinal cord, and one parotid gland. For patients with lateralized tumors, the ipsilateral neck side was treated up to the base of the skull; in the contralateral neck side, the treatment included the subdigastric nodes but excluded the jugular nodes at the base of the skull and most of the parotid gland. This was accomplished by a moderate gantry angle that was chosen using the BEV displays. Three months following the completion of radiation, the spared parotid glands retained on average 50% of their unstimulated and stimulated flows. In contrast, no saliva flow was measured from the unspared glands in any of the patients. Subjective xerostomia was absent, mild, or not different from that reported before radiation in 10 of 15 patients (67%). CONCLUSION: Partial parotid gland sparing is feasible by using three-dimensional planning in patients undergoing bilateral head and neck radiation. Approximately 50% of the saliva flow from the spared glands may be retained, and most patients thus treated have no or mild xerostomia in the early period after the completion of radiation. Whether tumor control and late complications are comparable to standard radiation will be assessed as more experience is gained.


Subject(s)
Head and Neck Neoplasms/radiotherapy , Parotid Gland/radiation effects , Radiation Protection/methods , Radiotherapy Planning, Computer-Assisted , Submandibular Gland/radiation effects , Xerostomia/prevention & control , Aged , Feasibility Studies , Female , Head and Neck Neoplasms/diagnostic imaging , Humans , Male , Middle Aged , Parotid Gland/diagnostic imaging , Prospective Studies , Radiography , Saliva/metabolism , Submandibular Gland/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...